Advanced Enzyme Technologies board meets Aug 8 for Q1 results and buyback

1 min read     Updated on 01 Aug 2026, 01:01 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Advanced Enzyme Technologies Limited is holding a board meeting on August 8, 2026, to approve Q1FY26 financial results and a share buyback proposal. The trading window remains closed until August 10, 2026, in accordance with SEBI regulations.

powered bylight_fuzz_icon
47115066

*this image is generated using AI for illustrative purposes only.

Advanced Enzyme Technologies Limited has scheduled a meeting of its Board of Directors for Saturday, August 08, 2026. The primary agenda includes the consideration and approval of the company's un-audited financial results for the first quarter ended June 30, 2026, as well as a proposal for the buyback of equity shares.

The decision to pursue a share buyback is subject to the provisions of the Companies Act, 2013, rules made thereunder, and the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended. This corporate action signals management's intent to return capital to shareholders or optimize capital structure, pending final approval during the scheduled session.

Key Agenda Items

The Board will address the following critical matters:

Agenda Item Details
Financial Results Un-audited Standalone and Consolidated results for Q1FY26 (ended June 30, 2026)
Capital Action Proposal for Buyback of Equity Shares and incidental matters

Trading Window Closure

In compliance with regulatory norms regarding insider trading prevention, the trading window for dealing in the securities of Advanced Enzyme Technologies Limited remains closed. The closure, initially intimated in a letter dated June 25, 2026, will continue until August 10, 2026. This restriction applies to all designated persons of the company who are in possession of unpublished price-sensitive information.

Regulatory Disclosures

The intimation regarding the board meeting and trading window closure was issued on August 01, 2026, and signed by Sanjay Basantani, Company Secretary and Head – Legal. The notice has been uploaded to the company's website at www.advancedenzymes.com and is accessible via the stock exchange websites at www.bseindia.com and www.nseindia.com . The company is listed on BSE Limited under Scrip Code 540025 and on the National Stock Exchange of India Ltd. under the trading symbol ADVENZYMES.

Historical Stock Returns for Advanced Enzyme Tech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.91%+0.27%+2.47%+6.17%-9.61%-21.08%

How might the proposed share buyback impact Advanced Enzyme Technologies' cash reserves and future capital expenditure plans for enzyme production expansion?

What specific metrics in the Q1FY26 un-audited results are likely to justify management's decision to return capital to shareholders via a buyback?

Could the share buyback signal a lack of high-return investment opportunities for the company, or is it primarily aimed at optimizing the debt-to-equity ratio?

Advanced Enzyme fixes July 24 record date for ₹1.35 dividend

1 min read     Updated on 10 Jul 2026, 05:02 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Advanced Enzyme Technologies Ltd has announced July 24, 2026 as the record date to determine shareholder eligibility for a final dividend of ₹1.35 per share for the financial year 2025-26. The dividend is subject to approval at the 37th Annual General Meeting, which will be held via video conference on July 31, 2026. The company also intimated the exchanges regarding the publication of the AGM notice in newspapers on July 09, 2026.

powered bylight_fuzz_icon
44630592

*this image is generated using AI for illustrative purposes only.

Advanced Enzyme Technologies Ltd has fixed Friday, July 24, 2026 as the record date for the payment of a final dividend of ₹1.35 per equity share of ₹2 each for the financial year 2025-26. The dividend recommendation is subject to approval by shareholders at the upcoming Annual General Meeting. This payout, if declared, will be paid on or after August 03, 2026, subject to deduction of tax at source.

The 37th Annual General Meeting of the company is scheduled to be held on Friday, July 31, 2026, through Video Conference and Other Audio Visual Means. The record date was fixed in accordance with Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Dates and Dividend Details

The following table outlines the critical dates and purpose of the corporate action:

Scrip Code Symbol Security Type Record Date Purpose
540025
(BSE)
ADVENZYMES
(NSE)
Equity shares July 24, 2026 For ascertaining the entitlement of the Members for payment of dividend, if declared at 37th AGM to be held on Friday, July 31, 2026

Shareholders registered in the records of the company on the record date will be eligible to receive the dividend, provided it is approved by the members during the AGM.

Newspaper Publication Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company intimated the exchanges regarding the copy of the newspaper publication. The advertisement was published in the Financial Express and Mumbai Lakshadeep on July 09, 2026, informing the members regarding the 37th AGM, Integrated Annual Report for financial year 2025-26, and the AGM Notice sent by electronic mode (emails) and Remote e-voting.

Historical Stock Returns for Advanced Enzyme Tech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.91%+0.27%+2.47%+6.17%-9.61%-21.08%

How will the final dividend payout impact Advanced Enzyme Technologies' free cash flow and capital allocation plans for FY2027?

What strategic growth initiatives or R&D investments does the company plan to highlight during the upcoming Annual General Meeting?

Is the current dividend payout ratio sustainable given the company's projected earnings growth for the upcoming fiscal year?

More News on Advanced Enzyme Tech

1 Year Returns:-9.61%